Current Report dated January 17, 2003
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
 
January 17, 2003
Date of Report (Date of earliest event reported)
 
 
SPECTRUM PHARMACEUTICALS, INC.
 
(Exact name of registrant as specified in its charter)
 
Delaware
   
000-28782
   
93-0979187
(State or other Jurisdiction
of Incorporation)
   
(Commission File Number)
   
(IRS Employer
Identification Number)
157 Technology Drive
Irvine, California
        
92618
(Zip Code)
(Address of principal executive offices)
          
 
(949) 788-6700
(Registrant’s telephone number, including area code)
 
N/A
(Former Name or Former Address, if Changed Since Last Report)

 
Item 5.    Other Events
 
On January 16, 2003, Spectrum Pharmaceuticals, Inc. (“Spectrum”) entered into agreements to sell an aggregate of 222,223 shares of its common stock at a negotiated purchase price per share of $2.25 and warrants to purchase up to an aggregate of 55,555 shares of its common stock at an exercise price per share of $3.25 to three institutional investors for an aggregate consideration of $500,001.75. Spectrum paid fees to a finder in connection with the investors participating in this offering. The shares and warrants were issued pursuant to an effective Registration Statement on Form S-3 (Reg. No. 333-53108). A copy of the forms of Securities Purchase Agreement and Warrant are attached hereto as Exhibits 10.1 and 4.1, respectively.
 
Item 7.    Exhibits
 
Exhibits:
     
  4.1
   
Form of Warrant
10.1
   
Form of Securities Purchase Agreement

2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
       
SPECTRUM PHARMACEUTICALS, INC.
Date:  January 17, 2003
     
By:
  
/s/    Rajesh C. Shrotriya
           
Name:
  
Rajesh C. Shrotriya, M.D.
           
Title:
  
Chairman of the Board,
Chief Executive Officer and President
 

3

 
EXHIBIT INDEX
 
Exhibits:
     
  4.1
   
Form of Warrant.
10.1
   
Form of Securities Purchase Agreement